Tag - Syngene Bengaluru Unit III biologics facility

Syngene Q1FY26: Revenue up 11%, PAT surges 59% as biologics and peptides scale

July 25, 2025

Strong start to FY26 with ₹875 Cr revenue; USFDA clearance, 20+ audits, and peptide lab expansion underline quality-first strategy Bengaluru, 23 July 2025 , ...

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30

Tag - Syngene Bengaluru Unit III biologics facility

Topics

Recent Posts

Featured

Follow Me